Lytix Biopharma Is A Clinical Stage Biotech Company Based In Oslonorwayestablished In 2003The Company Specializes In Developing Cancer Immunotherapies That Activate The Immune System To Combat Cancertheir Innovative Approach Utilizes Host Defense Peptide Derived Molecules Designed To Target And Kill Cancer Cellsincluding Those That Are Resistant To Other Treatments The Therapies Developed By Lytix Biopharma Aim To Expose Tumor Antigens To The Immune Systemleading To A Robust And Lasting T Cell Responsethis Technology Allows For Effective Treatment Across Various Cancer Typesboth As Standalone Therapies And In Combination With Other Treatmentslytix Biopharma Is Committed To Advancing Its Unique Peptide Based Technology To Improve Outcomes For Cancer Patients
No conferences found for this company.
| Company Name | Lytix Biopharma As |
| Country |
Norway
|
| Address | N/A |
| Telephone | N/A |
| N/A |
